Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2004-05-03
2008-11-11
Spector, Lorraine (Department: 1646)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S006120, C536S024300, C536S023500, C530S501000, C530S350000, C530S326000, C530S387100, C530S388250, C530S391300
Reexamination Certificate
active
07449303
ABSTRACT:
The present invention is based on the finding that plasma cell disorders such as Multiple Myeloma and Monoclonal Gammopathy of Unknown Significance are characterized by an increase in the expression of JAG2. Accordingly, the present invention provides a method for diagnosis of plasma cell disorders by detecting the expression or overexpression of JAG2. The expression or overexpression of JAG2 may be detected as increased mRNA transcripts or increased protein.
REFERENCES:
patent: 6136952 (2000-10-01), Li et al.
patent: 6291210 (2001-09-01), Sakano et al.
patent: 2001/0048930 (2001-12-01), Lamb et al.
patent: 2003/0232364 (2003-12-01), Shaughnessy et al.
patent: WO 00/25809 (2000-05-01), None
patent: WO 03/087159 (2003-10-01), None
patent: WO 03/087159 (2003-10-01), None
patent: WO 2004/076682 (2004-09-01), None
patent: WO 2004/099379 (2004-11-01), None
De Vos et al., Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays, Blood, 98(3):771-780, Aug. 2001.
Deng et al., Characterization, chromosomal localization, and the complete 30-kd DNA sequence of the human Jagged2 (JAG@) gene, Genomics, 63(1):133-138, 2000.
Hu et al., Profiling of differentially expressed cancer-realted genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC, Clin. Canc. Res., 7:3519-3525, Nov. 2001.
Gutgemann et al., Isolation of invastion-associated cDNAs in melanoma, Arch. Dermatol. Res. 293:283-290, 2001.
Gaiger, et al.; Identification of Genes Associated with Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance Using the Myeloma Microarray; European Journal of Cancer, Pergamon Press; Nov. 21, 2002, vol. 38, Paragraph 344; XP-002383846; p. S103.
Luo, et al.; Isolation and Functional Analysis of a cDNA for HumanJagged2, a Gene Encoding a Ligand for the Notch1 Receptor; Molecular and Cellular Biology, American Society for Microbiology; Washington, US; Oct. 1997; vol. 17, No. 10; XP-000938415; pp. 6057-6067.
Gray, et al.; Human Ligands of the Notch Receptor; American Journal of Pathology; Mar. 1999, vol. 154, No. 3; XP-000960906; pp. 785-794.
Almeida, et al.; Immunophenotypic and DNA Content Characteristics of Plasma Cells in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance; Pathologie et Biologie, L'Expansion Scientifique Francaise, Paris, FR; Feb. 1999, vol. 47, No. 2; XP-009067443; pp. 119-127.
Felli, et al.; Expression Pattern of Notch1, 2 and 3 and Jagged1 and 2 in Lymphoid and Stromal Thymus Components; Distinct Ligand—Receptor Interactions in Intrathymic T Cell Development; International Immunology, vol. 11, No. 77; XP-002384016; pp. 1017-1025.
Houde, et al.; Overexpression of the Notch Ligand JAG2 in Malignant Plasma Cells From Multiple Myeloma Patients and Cell Lines; Blood, Dec. 1, 2004, vol. 104, No. 12; XP-002380593; pp. 3697-3704.
Franziska, et al.; Activated Notch signaling might be a novel therapeutic target for multiple myeloma; Database Biosis [online]; Database accession No. PREV200400161099 abstract; Blood, Nov. 16, 2003, vol. 102, No. 11; p. 928a; XP-002454293.
Health Research , Inc.
Hodgson & Russ LLP
Kaufman Claire
Spector Lorraine
LandOfFree
Use of JAG2 expression in diagnosis of plasma cell disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of JAG2 expression in diagnosis of plasma cell disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of JAG2 expression in diagnosis of plasma cell disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4039315